Compare SQNS & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SQNS | SRTS |
|---|---|---|
| Founded | 2003 | 2010 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.9M | 48.9M |
| IPO Year | 2011 | 2016 |
| Metric | SQNS | SRTS |
|---|---|---|
| Price | $2.66 | $2.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.75 | $5.38 |
| AVG Volume (30 Days) | ★ 40.2K | 21.8K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | $33.45 | N/A |
| Revenue Next Year | $55.98 | $41.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.38 | $2.66 |
| 52 Week High | $8.85 | $5.49 |
| Indicator | SQNS | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 38.56 | 44.63 |
| Support Level | $2.40 | $2.85 |
| Resistance Level | $3.19 | $3.30 |
| Average True Range (ATR) | 0.15 | 0.12 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 2.08 | 26.67 |
Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.